VERA Vera Therapeutics, Inc.
$30.94▲ +3.17%
Healthcare
Other
After hours
$30.65▼ -0.95%
Oct 28, 4:46 PM ET
Volume 1.28M
Avg Volume (10D) 1.57M
Key Metrics & Fundamentals
Market Cap
$2.23B
P/E Ratio
–
Div Yield
0.00%
52W Range
23.05 - 56.05
% vs 50 MA
-3.43%
% vs 200 MA
-16.68%
RSI-14
52.7
MACD Histogram
+0.3300
Beta (1Y vs SPY)
1.34
Free Cash Flow
-$100.37M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$107.49M
COGS
–
Operating Exp
$112.49M
Operating Income
-$112.49M
EBIT
-$112.49M
Pretax Income
-$109.47M
Net Income
-$109.47M
EPS (Diluted)
-1.52
Price & Volume History
Loading chart…
Recent News
Vera Therapeutics' TRUTAKNA Delivers Strong Phase III IgA Nephropathy Results
MarketBeat · Oct 22, 2026 9:04 PM ET
Vera Therapeutics Announces Positive ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Presented at ASN Kidney Week 2026 and Published in the New England Journal of Medicine
GlobeNewswire · Oct 22, 2026 10:05 AM ET
Vera Therapeutics to Host ASN Kidney Week Investor Webcast and Third Quarter 2026 Financial Results Conference Webcast
GlobeNewswire · Oct 20, 2026 8:00 AM ET
Leerink Partners Initiates Vera Therapeutics at Market Perform With $34 Price Target
MT Newswires · Oct 12, 2026 7:12 AM ET
BofA Securities Adjusts Vera Therapeutics Price Target to $60 From $66, Maintains Buy Rating
MT Newswires · Oct 9, 2026 10:17 AM ET
Do Vera Therapeutics' (VERA) High-Profile IgAN Data Show Durable Moat or Crowded Mechanism Risk?
Simply Wall St. · Oct 8, 2026 11:15 AM ET
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire · Oct 2, 2026 4:05 PM ET
Vera Therapeutics Announces ORIGIN 3 Final Efficacy Analysis of TRUTAKNA™ (atacicept-vymj) in IgA Nephropathy Will be A Featured Late-breaking Oral Presentation at the Opening Plenary Session of ASN Kidney Week 2026
GlobeNewswire · Oct 2, 2026 9:24 AM ET
Will Vertex's Kidney Disease Pipeline Be a New Growth Engine?
Zacks · Sep 24, 2026 10:27 AM ET
2 ‘Strong Buy’ Stocks Where a Short Squeeze Could Be Brewing
TipRanks · Sep 17, 2026 1:58 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See VERA's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.